已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

The structure and function of the S1P1 receptor

G蛋白偶联受体 S1PR1型 鞘氨醇-1-磷酸受体 生物 细胞生物学 受体 1-磷酸鞘氨醇 视紫红质样受体 芬戈莫德 鞘氨醇激酶 鞘氨醇 信号转导 免疫学 生物化学 癌症研究 多发性硬化 血管内皮生长因子受体 血管内皮生长因子 血管内皮生长因子A 谷氨酸受体 代谢受体
作者
Catherine O’Sullivan,Kumlesh K. Dev
出处
期刊:Trends in Pharmacological Sciences [Elsevier BV]
卷期号:34 (7): 401-412 被引量:121
标识
DOI:10.1016/j.tips.2013.05.002
摘要

•Detailed amino acid analysis of the S1P1 receptor. •Overview of post-translational modification of the S1P1 receptor. •Description of S1P1 receptor internalization and persistent signaling. Sphingosine 1-phosphate (S1P) receptors (S1PRs) belong to the class A family of G protein-coupled receptors (GPCRs). S1PRs are widely expressed on many cell types, including those of the immune, cardiovascular, and central nervous systems. The S1PR family is rapidly gaining attention as an important mediator of many cellular processes, including cell differentiation, migration, survival, angiogenesis, calcium homeostasis, inflammation and immunity. Importantly, S1PRs are known drug targets for multiple sclerosis (MS), for which the newly developed oral therapy fingolimod, an S1PR modulator, has recently been approved for clinical use. Much progress has also recently been made in the field of structural biology and in the modeling of heterotrimeric GPCRs allowing the crystal structure of the S1PR1 subtype to be elucidated and key interactions defined. Here, we outline the structure and function of S1PR1, highlighting the key residues involved in receptor activation, signaling, transmembrane interactions, ligand binding, post-translational modification, and protein–protein interactions. Sphingosine 1-phosphate (S1P) receptors (S1PRs) belong to the class A family of G protein-coupled receptors (GPCRs). S1PRs are widely expressed on many cell types, including those of the immune, cardiovascular, and central nervous systems. The S1PR family is rapidly gaining attention as an important mediator of many cellular processes, including cell differentiation, migration, survival, angiogenesis, calcium homeostasis, inflammation and immunity. Importantly, S1PRs are known drug targets for multiple sclerosis (MS), for which the newly developed oral therapy fingolimod, an S1PR modulator, has recently been approved for clinical use. Much progress has also recently been made in the field of structural biology and in the modeling of heterotrimeric GPCRs allowing the crystal structure of the S1PR1 subtype to be elucidated and key interactions defined. Here, we outline the structure and function of S1PR1, highlighting the key residues involved in receptor activation, signaling, transmembrane interactions, ligand binding, post-translational modification, and protein–protein interactions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xiaofei应助忧郁的夜玉采纳,获得10
2秒前
ttgx完成签到,获得积分10
3秒前
5秒前
111111完成签到,获得积分10
5秒前
顾矜应助V0采纳,获得10
6秒前
程风破浪发布了新的文献求助30
9秒前
10秒前
淡然之槐完成签到 ,获得积分10
11秒前
Spongeeeee发布了新的文献求助10
12秒前
AAA完成签到 ,获得积分10
13秒前
大模型应助破碎虚空采纳,获得10
18秒前
nano完成签到 ,获得积分10
19秒前
YuuuY完成签到 ,获得积分10
20秒前
悦仙完成签到 ,获得积分10
25秒前
刻苦雁完成签到,获得积分10
25秒前
Joy发布了新的文献求助10
26秒前
26秒前
小菲完成签到 ,获得积分10
28秒前
29秒前
30秒前
小宋完成签到,获得积分10
32秒前
32秒前
34秒前
tongluobing完成签到,获得积分10
34秒前
文静菠萝发布了新的文献求助10
35秒前
小宋发布了新的文献求助10
35秒前
范特西完成签到 ,获得积分10
37秒前
woleo发布了新的文献求助10
39秒前
41秒前
Moonpie应助wink采纳,获得10
42秒前
gkhsdvkb完成签到 ,获得积分10
43秒前
44秒前
李爱国应助yeluoyezhi采纳,获得10
44秒前
45秒前
忧郁的夜玉完成签到,获得积分10
45秒前
46秒前
Mitty完成签到 ,获得积分10
47秒前
科研通AI6.2应助高源伯采纳,获得10
47秒前
lili发布了新的文献求助10
49秒前
一个西藏完成签到 ,获得积分10
52秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
Development Across Adulthood 600
天津市智库成果选编 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6444176
求助须知:如何正确求助?哪些是违规求助? 8258069
关于积分的说明 17590455
捐赠科研通 5503078
什么是DOI,文献DOI怎么找? 2901254
邀请新用户注册赠送积分活动 1878273
关于科研通互助平台的介绍 1717595